Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

Table of Contents

1 Introduction
1.1 Objectives of Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1.1 Research Methodology Steps
2.1.2 Secondary and Primary Research Methodology
2.1.2.1 Secondary Research
2.1.2.2 Primary Research
2.1.3 Key Data From Primary Sources
2.1.4 Key Insights From Primary Sources
2.1.4.1 Key Industry Insights
2.1.5 Market Size Estimation Methodology
2.1.6 Research Design
2.1.7 Market Data Validation and Triangulation
2.1.8 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Market Overview of Neuromodulation
4.2 Global Neuromodulation Market, By Type
4.3 Geographic Analysis of the Deep Brain Stimulation Market, By Application
4.4 Internal Neuromodulation Market, By Modality
4.5 Geographical Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Segmentation of Neuromodulation
5.3 Market Dynamics of Neuromodulation
5.1 Drivers
5.1.1.1 Rising Prevalence of Neurological Disorders to Spur Market Growth
5.1.1.2 Unprecedented Increase in the Aging Population to Fuel Market Growth
5.1.1.3 Strong Product Pipeline to Propel the Market
5.1.1.4 Expanded Target Applications and New Indications are Expected to Stimulate the Growth of Neuromodulation Devices
5.1.1.5 Investments and Funds – an Impetus for Market Growth
5.2 Restraints
5.2.1.1 Unfavorable Reimbursement Scenario Hinders Market Growth
5.2.1.2 Lack of Trained Professionals Likely to Hamper Market Growth
5.3 Opportunities
5.3.1.1 Expansion in Emerging Economies

6 Global Neuromodulation Market, By Technology
6.1 Introduction
6.2 Internal Neuromodulation
6.2.1 Spinal Cord Stimulation (SCS)
6.2.2 Deep Brain Stimulation (DBS)
6.2.3 Vagus Nerve Stimulation (VNS)
6.2.4 Sacral Nerve Stimulation (SNS)
6.2.5 Gastric Electrical Stimulation (GES)
6.3 External Neuromodulation (Non-Invasive)
6.3.1 Transcutaneous Electrical Nerve Stimulation (Tens)
6.3.2 Transcranial Magnetic Stimulation (TMS)
6.3.3 Respiratory Electrical Stimulation (RES)

7 Global Neuromodulation Market, By Application
7.1 Introduction
7.2 Spinal Cord Stimulation (SCS) Market, By Application
7.2.1 Failed Back Syndrome (FBSS)
7.2.2 Chronic Pain
7.2.3 Ischemia
7.3 Deep Brain Stimulation (DBS) Market, By Application
7.3.1 Parkinson’s Disease
7.3.2 Tremor
7.3.3 Depression
7.3.4 Other Dbs Applications
7.4 Sacral Nerve Stimulation Market, By Application
7.4.1 Urine Incontinence
7.4.2 Fecal Incontinence
7.5 Vagus Nerve Stimulation Market, By Application
7.5.1 Epilepsy
7.5.2 Other Vns Applications
7.6 Gastric Electrical Stimulation Market, By Application
7.6.1 Gastroparesis
7.6.2 Obesity
7.7 Transcutaneous Electrical Nerve Stimulation Market, By Application
7.7.1 Treatment Resistant Depression
7.7.2 Other Tens Applications
7.8 Repetitive Transcranial Magnetic Stimulation Market, By Application
7.8.1 Depression
7.8.2 Migraine Headache
7.9 Respiratory Electrical Stimulation Market, By Application
7.9.1 Spinal Cord Injury

8 Neuromodulation Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.1.1 Rising Prevalence of Chronic Diseases In The U.S.
8.2.1.2 Increasing Aging Population In The U.S.
8.2.1.3 Increasing Lyme Disease Cases In The U.S.
8.2.1.4 Conferences & Annual Meetings To Increase Exposure of Neuromodulation
8.2.2 Canada
8.2.2.1 Increasing Incidence of Lyme Disease In Canada
8.2.2.2 Increasing Incidences of Cancer And Diabetes
8.2.3 Europe
8.2.3.1.1 Rapidly Aging Population In Europe
8.2.3.1.2 Conferences & Annual Meetings To Increase Exposure To Neuromodulation in the European Market
8.2.3.2 Germany
8.2.3.2.1 Rising Prevalence of Parkinson’s Disease In Germany
8.2.3.3 U.K.
8.2.3.3.1 Rising Prevalence of Diabetes In The U.K.
8.2.3.3.2 Rise In CVD Prevalence In The U.K.
8.2.3.4 France
8.2.3.4.1 Rising Incidences of Alzheimer's Disease And Dementia
8.2.3.5 Rest of Europe
8.2.3.5.1 High Diabetes Prevalence In Russia, Turkey, Poland, Romania, And Ukraine
8.2.4 Asia-Pacific
8.2.4.1 Japan
8.2.4.1.1 Rising Adoption of Neurostimulation
8.2.4.2 China
8.2.4.2.1 High Diabetes Incidences And Rapidly Aging Population
8.2.4.3 India
8.2.4.3.1 Increasing Geriatric Population & High Diabetes Incidence
8.2.4.3.2 Conferences On Neuromodulation & Pain Management In India
8.2.4.4 Rest of Asia-Pacific (ROAPAC)
8.2.4.4.1 Increasing Prevalence of Parkinson’s Disease In Singapore
8.2.4.4.2 Conferences On Neuromodulation In Australia
8.2.5 Rest of The World
8.2.5.1.1 Increasing Incidences of Cancer In Latin America
8.2.5.1.2 Rise In Aging Population & Prevalence of Diabetes

9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis fo Neuromodulation, By Key Player
9.2.1 Introduction
9.3 Medtronic, Inc.
9.4 Boston Scientific Corporation
9.5 ST. Jude Medical, Inc.
9.6 Competitive Scenario
9.6.1 Market Development of Neuromodulation
9.6.2 Agreements, Collaborations, Mergers, and Partnerships
9.6.3 New Product Launches
9.6.4 Acquisitions
9.6.5 Expansion

10 Company Profiles
10.1 Introduction
10.2 Medtronic, Inc.
10.2.1 Business Overview
10.2.2 Medtronic, Inc.: Company Snapshot
10.2.3 Products & Services
10.2.4 Recent Developments
10.2.5 MnM View
10.3 Boston Scientific Corporation
10.3.1 Business Overview
10.3.2 Boston Scientific Corporation: Company Snapshot
10.3.3 Product Offerings
10.3.4 Recent Developments
10.3.5 MnM View
10.4 ST. Jude Medical, Inc.
10.4.1 Business Overview
10.4.2 ST Jude Medical, Inc.: Company Snapshot
10.4.3 Product Offerings:
10.4.4 Recent Developments
10.4.5 MnM View
10.5 Cyberonics, Inc.
10.5.1 Business Overview
10.5.2 Cyberonics, Inc.: Company Snapshot
10.5.3 Product Portfolio
10.5.4 Recent Developments
10.6 Nevro Corporation
10.6.1 Business Overview
10.6.2 Nevro Corporation: Company Snapshot
10.6.3 Product Offerings
10.6.4 Recent Developments
10.7 Neurosigma, Inc.
10.7.1 Business Overview
10.7.2 Neurosigma, Inc.: Company Snapshot
10.7.3 Product Offerings
10.7.4 Recent Developments
10.8 Neuropace, Inc.
10.8.1 Business Overview
10.8.2 Neuropace, Inc.: Company Snapshot
10.8.3 Product Offerings
10.8.4 Recent Developments
10.9 Biocontrol Medical
10.9.1 Business Overview
10.9.2 Biocontrol Medical: Company Snapshot
10.9.3 Product Offerings
10.9.4 Recent Developments
10.10 Synapse Biomedical, Inc.
10.10.1 Business Overview
10.10.2 Synapse Biomedical, Inc.: Company Snapshot
10.10.3 Product Offerings
10.10.4 Recent Developments
10.11 Neuronetics, Inc.
10.12 Business Overview
10.12.1 Neuronetics, Inc.: Company Snapshot
10.12.2 Product and Service Offerings
10.12.3 Recent Developments

11 Appendix
11.1 Discussion Guide
11.2 Company Developments (2012-2015)
11.2.1 Medtronic, Inc.
11.2.2 Boston Scientific Corporation
11.2.3 ST Jude Medical, Inc.
11.2.4 Neurosigma, Inc.
11.3 Introducing RT: Real-Time Market Intelligence
11.4 Available Customizations
11.5 Related Reports

List of Tables

Table 1 Increasing Incidence of Neurological Disorders is Propelling the Growth of the Global Neuromodulation Market
Table 2 Unfavourable Reimbursement Structure is Restraining the Growth of the Global Neuromodulation Market
Table 3 Expansion in Emerging Markets has a Huge Potential for Growth in the Global Neuromodulation Market
Table 4 Global Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 5 Internal Neuromodulation Market Size, By Region, 2013-2020 ($Million)
Table 6 Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 7 Internal Neuromodulation Market Size, By Modality, 2013-2020 (Units)
Table 8 Spinal Cord Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 9 Spinal Cord Stimulation Market Size, 2013-2020 (Units)
Table 10 Deep Brain Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 11 Deep Brain Stimulation Market Size, 2013-2020 (Units)
Table 12 Vagus Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 13 Vagus Nerve Stimulation Market Size, 2013-2020 (Units)
Table 14 Sacral Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 15 Sacral Nerve Stimulation Market Size, 2013-2020 (Units)
Table 16 Gastric Electrical Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 17 Gastric Electrical Stimulation Market Size, 2013-2020 (Units)
Table 18 External Neuromodulation Market Size, By Region, 2013-2020 ($Million)
Table 19 External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 20 External Neuromodulation Market Size, By Modality, 2013-2020 (Units)
Table 21 Transcutaneous Electrical Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 22 Gastric Electrical Stimulation Market Size, 2013-2020 (Units)
Table 23 Transcranial Magnetic Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 24 Transcranial Magnetic Stimulation Market Size, 2013-2020 (Units)
Table 25 Respiratory Electrical Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 26 Respiratory Electrical Stimulation Market Size, 2013-2020 (Units)
Table 27 Global Spinal Cord Stimulation Market, By Application, 2013–2020 ($Million)
Table 28 Global Deep Brain Stimulation Market, By Application, 2013–2020 ($Million)
Table 29 Global Sacral Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 30 Global Vagus Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 31 Global Gastric Electrical Stimulation Market, By Application, 2013–2020 ($Million)
Table 32 Global Transcutaneous Electrical Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 33 Global Transcranial Magnetic Stimulation Market, By Application, 2013–2020 ($Million)
Table 34 Neuromodulation Market Size, By Region, 2013-2020($Million)
Table 35 North America: Neuromodulation Market Size, By Country, 2013–2020 ($Million)
Table 36 North America: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 37 North America: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 38 North America: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 39 U.S.: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 40 U.S.: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 41 U.S.: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 42 Canada: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 43 Canada: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 44 Canada: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 45 Europe: Neuromodulation Market Size, By Country, 2013-2020 ($Million)
Table 46 Europe: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 47 Europe: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 48 Europe: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 49 Germany: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 50 Germany: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 51 Germany: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 52 U.K.: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 53 U.K.: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 54 U.K.: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 55 France: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 56 France: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 57 France: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 58 Rest of Europe: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 59 Rest of Europe: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 60 Rest of Europe: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 61 Asia-Pacific: Neuromodulation Market Size, By Country, 2013-2020 ($Million)
Table 62 Asia-Pacific: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 63 Asia-Pacific: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 64 Asia-Pacific: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 65 Japan: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 66 Japan: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 67 Japan: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 68 China: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 69 China: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 70 China: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 71 India: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 72 India: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 73 India: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 74 ROAPAC: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 75 ROAPAC: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 76 ROAPAC: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 77 Rest of the World: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 78 Rest of the World: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 79 Rest of the World: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 80 Recent Developments, 2012–2014
Table 81 Recent Developments, 2012–2014
Table 82 Recent Developments, 2012–2014
Table 83 Recent Developments, 2012–2014
Table 84 Recent Developments, 2012–2014

List of Figures

Figure 1 Market Segmentation
Figure 2 Market Research Methodology Steps
Figure 3 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Internal Neuromodulation Segment to Witness the Highest CAGR of11.4% From 2015 to 2020
Figure 8 Deep Brain Stimulation to Grow at the Highest CAGR of 14.2% During the Forecast Period
Figure 9 Transcutaneous Electrical Nerve Stimulation is Expected to Command the Largest Share in 2015
Figure 10 Parkinson’s Disease is Expected to Command the Largest Share in 2015
Figure 11 Asia-Pacific Slated to Witness the Highest Growth in the Neuromodulation Market During the Forecast Period
Figure 12 Attractive Opportunities in the Neuromodulation Market
Figure 13 Internal Modulation Technology to Witness the Highest Growth During the Forecast Period
Figure 14 North America to Dominate the Neuromodulation Market
Figure 15 Deep Brain Stimulation Segment to Witness Highest Growth Rate During the Forecast Period
Figure 16 Asia-Pacific to Witness Highest Growth Rate From 2015 to 2020
Figure 17 Global Neuromodulation Market, By Type
Figure 18 Internal Neuromodulation Segment to Grow at the Highest CAGR of11.2% During the Forecast Period
Figure 19 Asia-Pacific to Grow at the Highest CAGR of 14.9% During the Forecast Period
Figure 20 Asia-Pacific to Grow at the Highest CAGR of 13.4% During the Forecast Period
Figure 21 Transcranial Magnetic Stimulation to Grow at the Highest CAGR During the Forecast Period
Figure 22 Global  Internal Neuromodulation  Market, By Application
Figure 23 Global  External Neuromodulation  Market, By Application
Figure 24 North America is Expected to Command the Largest Share of the Global Market in 2015
Figure 25 U.S. to Witness the Highest Growth in the Global Market in North America (2015)
Figure 26 Germany to Witness the Highest Growth in the Global Neuromodulation Market in Europe (2015)
Figure 27 Asia-Pacific, the Fastest-Growing Segment in the Global Market
Figure 28 RoW Expected to Grow at A CAGR of 13.3% During 2015 to 2020
Figure 29 Market Share Analysis of Neuromodulation, By Key Player, 2014
Figure 30 Neuromodulation Strategies Adopted By Key Players Over the Last Four Years (2012-2015)
Figure 31 Battle for Market Share of Neuromodulation: Market Develpoment was the Key Strategy
Figure 32 Neuromodulation Geographical Revenue Mix of Top Players

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Procalcitonin Antibody Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Published: 15-Jun-2018        Price: US 3480 Onwards        Pages: 152

Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantit......

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Procalcitonin Antibody Market 2018, Forecast to 2023

Published: 15-Jun-2018        Price: US 4880 Onwards        Pages: 150

Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantit......

Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Published: 15-Jun-2018        Price: US 3480 Onwards        Pages: 132

Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival. EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that's why most sk......

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market 2018, Forecast to 2023

Published: 15-Jun-2018        Price: US 4880 Onwards        Pages: 136

Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival. EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that's why most sk......

Creatinine Measurement Market by Product (Kits, Reagents), Test Type (Jaffe method, Enzymatic creatinine method), Sample (Serum Creatinine, Urine) and End User (Hospitals, Diagnostic Laboratories), Region (North America, Europe) - Global Forecast to 2023

Published: 11-Jun-2018        Price: US 5650 Onwards        Pages: 210

“The global creatinine measurement market projected to grow at a CAGR of 8.4%.” The global creatinine measurement market is expected to reach USD 564.5 million by 2023 from USD 377.2 million in 2018, at a CAGR of 8.4%. Factors such as the increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, favorable government initiatives to promote renal health, rapid growth in the geriatric population, ......

Global Human Micobiome Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Published: 09-Jun-2018        Price: US 3480 Onwards        Pages: 152

The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bact......

Global Microbial Identification Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Published: 08-Jun-2018        Price: US 3480 Onwards        Pages: 150

Microbial identification is the process of identifying harmful bacteria and fungi that may contaminate raw materials, manufacturing facilities and branded products. Accurate and definitive microbial identification is critical for disease diagnosis and treatment of infections. Bacterial identification is widely used across manufacturing facilities, clinical settings and environmental studies. In this report our statistical date only content monitoring equipment. Scope of the Report......

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Microbial Identification Market 2018, Forecast to 2023

Published: 08-Jun-2018        Price: US 4880 Onwards        Pages: 145

Microbial identification is the process of identifying harmful bacteria and fungi that may contaminate raw materials, manufacturing facilities and branded products. Accurate and definitive microbial identification is critical for disease diagnosis and treatment of infections. Bacterial identification is widely used across manufacturing facilities, clinical settings and environmental studies. In this report our statistical date only content monitoring equipment. Scope of the Report......

Multiplex Assays Market by Product (Consumables, Instruments), Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence), Application (R&D, Diagnosis), End User (Pharma & Biotech, Reference Laboratory, Hospital) - Global Forecast to 2023

Published: 07-Jun-2018        Price: US 5650 Onwards        Pages: 142

“The global multiplex assays market is projected to grow at a CAGR of 7.5%.” The global multiplex assays market is projected to reach USD 3.35 billion in 2023 from USD 2.33 billion in 2018, at CAGR of 7.5%. Multiplex assays enable the simultaneous detection of multiple analytes in a single run/cycle of the assay. The use of multiplex assays in companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs